Assignee
ESTEVE PHARMACEUTICALS SA
ES·26 granted patents·22 pending applications·1 citations·filing 2014–2024
Top patents by PatentIndex Score
48 records- 0185US11919926B2Method of treating HIV-1 infection utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopesESTEVE PHARMACEUTICALS SA·Filed 2021·Granted Mar 5, 2024·1 cites·46 claims
- 0275US11478488B2Co-crystals of tramadol and coxibsESTEVE PHARMACEUTICALS SA·Filed 2019·Granted Oct 25, 2022·0 cites·6 claims
- 0364US2025075194A1Adenoassociated virus vectors for the treatment of mucopolysaccharidoses type iv aESTEVE PHARMACEUTICALS SA·Filed 2024·Application pending·0 cites
- 0462US2023057884A1Co-crystals of tramadol and coxibsESTEVE PHARMACEUTICALS SA·Filed 2022·Application pending·0 cites
- 0560US2023020469A1Use of co-crystals of tramadol and celecoxib for treating pain while reducing the abuse liability of tramadolESTEVE PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 0660US2020360306A1Use of co-crystals of tramadol and celecoxib for treating pain while reducing the abuse liability of tramadolESTEVE PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 0759US11649248B2Oxadiazaspiro compounds for the treatment of drug abuse and addictionESTEVE PHARMACEUTICALS SA·Filed 2020·Granted May 16, 2023·0 cites·18 claims
- 0859US10745361B2Piperazine derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2019·Granted Aug 18, 2020·0 cites·13 claims
- 0955US2020339597A1Alkyl and aryl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 1054US12146169B2Adenoassociated virus vectors for the treatment of mucopolysaccharidoses type IV AESTEVE PHARMACEUTICALS SA·Filed 2019·Granted Nov 19, 2024·0 cites·12 claims
- 1152US10351535B2Piperazine derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2014·Granted Jul 16, 2019·0 cites·18 claims
- 1251US11236110B2Salts of (R)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-oneESTEVE PHARMACEUTICALS SA·Filed 2018·Granted Feb 1, 2022·0 cites·10 claims
- 1351US2025002503A1Oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotectionESTEVE PHARMACEUTICALS SA·Filed 2022·Application pending·0 cites
- 1448US2024059690A1PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAINESTEVE PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 1546US2021395249A1New alkoxyaminopyridine derivatives for treating pain and pain related conditionsESTEVE PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 1645US10640468B21-(4-(2-((1-(3,4-difluorophenyl)-1H-pyrazol-3-Yl)methoxy)ethyl)piperazin-1- Yl)ethanone saltsESTEVE PHARMACEUTICALS SA·Filed 2016·Granted May 5, 2020·0 cites·5 claims
- 1744US11401270B2Alcoxyamino derivatives for treating pain and pain related conditionsESTEVE PHARMACEUTICALS SA·Filed 2018·Granted Aug 2, 2022·0 cites·25 claims
- 1844US10927128B2Oxadiazaspiro compounds for the treatment of drug abuse and addictionESTEVE PHARMACEUTICALS SA·Filed 2016·Granted Feb 23, 2021·0 cites·22 claims
- 1944US2022042043A1Recombinant vectors for the long term treatment of mucchopolysacharidosisESTEVE PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 2044US2020207759A1New propanamine derivatives for treating pain and pain related conditionsESTEVE PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 2144US2021395254A1New tetrahydropyrimidodiazepin and tetrahydropyridodiazepin compounds for treating pain and pain related conditionsESTEVE PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 2243US12479830B2Homopiperazinyl and homopiperidinyl quinazolin-4(3H)-one derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2020·Granted Nov 25, 2025·0 cites·19 claims
- 2343US10941138B2Quinoline and isoquinoline derivatives for treating pain and pain related conditionsESTEVE PHARMACEUTICALS SA·Filed 2017·Granted Mar 9, 2021·0 cites·14 claims
- 2442US11338046B2Adenoassociated virus vectors for the treatment of mucopolysaccharidosesESTEVE PHARMACEUTICALS SA·Filed 2017·Granted May 24, 2022·0 cites·14 claims
- 2542US11111220B2Propanamine derivatives for treating pain and pain related conditionsESTEVE PHARMACEUTICALS SA·Filed 2018·Granted Sep 7, 2021·0 cites·21 claims
- 2642US2019142840A1Use of sigma receptor ligands in cancerESTEVE PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 2740US2020270237A1New alkoxyamino compounds for treating pain and pain related conditionsESTEVE PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 2839US12201095B2Animal model of mucopolysaccharidoses type IVAESTEVE PHARMACEUTICALS SA·Filed 2019·Granted Jan 21, 2025·0 cites·8 claims
- 2939US2020123115A1Compounds having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 3038US2020010457A1Tetrahydropyran and tetrahydrothiopyran amide derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 3137US10590140B2Tetrahydropyrimidodiazepine and dihydropyridodiazepine compounds for treating pain and pain related conditionsESTEVE PHARMACEUTICALS SA·Filed 2017·Granted Mar 17, 2020·0 cites·21 claims
- 3237US10562908B2Ortho substituted phenylpyrazolo- and phenylpyrrolo-pyridazine derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2017·Granted Feb 18, 2020·0 cites·17 claims
- 3337US10508114B2Spiro-isoquinoline-4,4′-piperidine compounds having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2016·Granted Dec 17, 2019·0 cites·21 claims
- 3437US2020002283A1Pyrazole derivatives having activity against painESTEVE PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 3537US2020190087A12-phenyl-2h-pyrazolo[3,4-d]pyridazine derivatives having activity against painESTEVE PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 3636US12398403B2Methods for the manufacture of recombinant viral vectorsESTEVE PHARMACEUTICALS SA·Filed 2020·Granted Aug 26, 2025·0 cites·10 claims
- 3736US10351549B2Amide derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2016·Granted Jul 16, 2019·0 cites·25 claims
- 3836US2019055217A1Piperidinylalkylamide derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 3935US10689398B2OXA-Diazaspiro compounds having activity against painESTEVE PHARMACEUTICALS SA·Filed 2016·Granted Jun 23, 2020·0 cites·20 claims
- 4035US2019345146A1Nitrogen containing bicyclic derivatives for treating pain and pain related conditionsESTEVE PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 4135US2020190081A1Meta substituted phenylpyrazolo- and phenylpyrrolo- pyridazine derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 4234US10421750B2Substituted morpholine derivatives having activity against painESTEVE PHARMACEUTICALS SA·Filed 2016·Granted Sep 24, 2019·0 cites·20 claims
- 4334US2020062767A1Substituted pyrrolidinyl and piperidinyl pyrazolopyridazine derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 4433US2020199127A1(hetero)arylalkylamino-pyrazolopyridazine derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 4532US10807970B2Tetrahydropyran and thiopyran derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2017·Granted Oct 20, 2020·0 cites·24 claims
- 4631US10577360B2Arylamide derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2017·Granted Mar 3, 2020·0 cites·19 claims
- 4730US10407428B2Spiro-isoquinoline-1,4′-piperidine compounds having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2015·Granted Sep 10, 2019·0 cites·17 claims
- 4829US10428051B2Substituted amide derivatives having multimodal activity against painESTEVE PHARMACEUTICALS SA·Filed 2016·Granted Oct 1, 2019·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when ESTEVE PHARMACEUTICALS SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →